Nerve stimulation boosts botulinum toxin action in spasticity
- PMID: 15726575
- DOI: 10.1002/mds.20395
Nerve stimulation boosts botulinum toxin action in spasticity
Abstract
Spasticity leads to functional and structural changes in nerves and muscles, which alter skeletal muscle function. To evaluate whether short-term electrical nerve stimulation (NS) improves the effect of botulinum toxin in spastic skeletal muscle, we studied changes in the amplitude of the compound muscle action potential (CMAP) recorded from the extensor digitorum brevis (EDB) muscle in response to peroneal nerve stimulation at the ankle after injection of botulinum toxin type A (BTXA) alone or combined with short-term NS. In paraparetic patients, both EDB muscles were injected with BTXA; and NS was applied to one EDB muscle alone. All patients received a 30-minute session of electrical NS once a day for 5 consecutive days after BTXA injection. We used two different stimulation frequencies (low-frequency, 4 Hz; and high-frequency, 25 Hz). EDB-CMAP amplitudes were evaluated before BTXA injection (day 0) and changes in CMAP amplitude, expressed as a percentage (CMAP%), were measured at various time points over a 30-day period after BTXA injection. We compared changes in the CMAP% amplitude on the stimulated and contralateral nonstimulated sides. We also studied the electromyographic activity recorded from EDB muscles over a 30-day period. CMAP% amplitudes measured at all time points after BTXA injections were significantly reduced in both EDB muscles. On days 4, 10, and 15, the CMAP% amplitude reduction was significantly greater for the low-frequency stimulated EDB than for the contralateral nonstimulated EDB. No significant differences in CMAP% were observed for the high-frequency stimulated and nonstimulated EDB. After BTXA injection, spontaneous activity appeared in both EDB muscles; but it appeared earlier and involved larger areas in the stimulated than in the nonstimulated EDB. In conclusion, short-term NS accelerates the effectiveness of intramuscular BTXA injections on the neuromuscular blockade in patients with spastic paraparesis and could induce a rapid and persistent improvement in spasticity. Its action probably arises mainly from low-frequency NS.
Copyright 2005 Movement Disorder Society.
Similar articles
-
The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.Mov Disord. 1997 Jan;12(1):89-94. doi: 10.1002/mds.870120115. Mov Disord. 1997. PMID: 8990059
-
Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test.Mov Disord. 2006 Oct;21(10):1737-41. doi: 10.1002/mds.21051. Mov Disord. 2006. PMID: 16874756
-
Effect of short-term electrical stimulation before and after botulinum toxin injection.J Rehabil Med. 2011 Apr;43(5):420-3. doi: 10.2340/16501977-0790. J Rehabil Med. 2011. PMID: 21448556
-
[Botulinum toxin type A treatment of upper limb spasticity].Wien Klin Wochenschr. 2001;113 Suppl 4:16-9. Wien Klin Wochenschr. 2001. PMID: 15506047 Review. German.
-
Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.Disabil Rehabil. 2007 Dec 15;29(23):1806-12. doi: 10.1080/09638280701568205. Disabil Rehabil. 2007. PMID: 18033605 Review.
Cited by
-
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Neuropsychiatr Dis Treat. 2012;8:35-48. doi: 10.2147/NDT.S17923. Epub 2012 Jan 13. Neuropsychiatr Dis Treat. 2012. PMID: 22275844 Free PMC article.
-
Vocal exercise versus voice rest following botulinum toxin injections: a randomized crossover trial.Ann Otol Rhinol Laryngol. 2009 Nov;118(11):759-63. Ann Otol Rhinol Laryngol. 2009. PMID: 19999359 Free PMC article. Clinical Trial.
-
AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review.Toxins (Basel). 2022 Oct 26;14(11):734. doi: 10.3390/toxins14110734. Toxins (Basel). 2022. PMID: 36355984 Free PMC article.
-
Neurophysiological effects of botulinum toxin type A.Neurotox Res. 2006 Apr;9(2-3):109-14. doi: 10.1007/BF03033927. Neurotox Res. 2006. PMID: 16785106 Review.
-
[Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].Nervenarzt. 2011 Apr;82(4):481-95. doi: 10.1007/s00115-010-3172-8. Nervenarzt. 2011. PMID: 21079908 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous